NHS needs to ramp up non-emergency treatments by 10% to tackle pandemic backlog

Analysis in The Lancet reveals the NHS must treat at least 10% more non-emergency cases monthly to reduce the pandemic-induced backlog, with over 7.2 million referrals pending as of October 2022.

Liver Concerns Foil GLP-1 Drug; Not Enough Menopause Training; Wegovy Supply Limits

Pfizer dropped development of lotiglipron, its investigational GLP-1 receptor agonist for obesity, due to elevated liver enzymes; could other agents in the drug class carry

August 16, 2023

Thermo Fisher to buy real-world evidence company CorEvitas for $913M

Dive Brief: Thermo Fisher Scientific said Thursday it has reached an agreement to acquire CorEvitas, a Waltham, Mass.-based company that provides real-world evidence for pharma

July 6, 2023

Outset Medical to pay down debt after raising nearly $300M

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Outset Medical expects to receive

January 7, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.